Boston Scientific disclosed executive pay for 2024 and reported a rebound in its median employee's pay after a large drop the ...

Boston Scientific Corp.'s (NYSE:BSX) Executive Vice President and Chief Financial Officer, Daniel J. Brennan, recently engaged in a series of stock transactions, according to a recent SEC filing.

On Monday, Stifel analysts increased their price target on Boston Scientific Corporation ... and robust revenue growth of 17.61%. CFO Daniel Brennan's remarks were also a key point of reference ...

CFO Daniel Brennan reported Q4 consolidated ... with management affirming adequate capacity to meet growing FARAPULSE demand. Boston Scientific delivered another strong quarter, exceeding ...

Boston Scientific Corporation (NYSE ... representing growth of 12% to 14%. Daniel Brennan will provide more details on the financials, and then I'll provide some initial highlights in 2024.

Climbing sales for a made-in-Minnesota system treating atrial fibrillation helped sustain Boston Scientific ... Chief Financial Officer Daniel Brennan said Wednesday that the company does ...